Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03660631 · ClinicalTrials.gov registry record · NA

Dissemination of the Cardiovascular Risk Service

A NA study of Hypertension and Diabetes Mellitus, sponsored by Korey Kennelty.

Active
Registry status
NA
Development phase
542
Enrollment target
14
Study locations

NCT03660631 is a NA study of Hypertension and Diabetes Mellitus that is active but no longer recruiting, run by Korey Kennelty. The registered enrollment target is 542 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (85% lower). The trial reports 14 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03660631, a NA study of Hypertension and Diabetes Mellitus, is active but no longer recruiting, sponsored by Korey Kennelty.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
542 participants
Enrollment target
14
Study locations

Study Summary

The objective of this study is to evaluate the implementation of of a remote, pharmacist-led cardiovascular risk service (CVRS) in 12 large, organizationally and culturally diverse hospitals and health-systems, many with high proportions of minority and underserved patients.

Interventions

  • BEHAVIORAL CVRS Intervention

Study Locations (14)

Iowa

  • Genesis Family Medical Center - Davenport
  • University of Iowa - Iowa City
  • UIHC River Crossing - Riverside
  • Siouxland Family Medicine Center - Sioux City
  • Northeast Iowa Family Practice Center - Waterloo

Illinois

  • University of Illinois at Chicago: Mile Square Health Center - Chicago
  • Carle Foundation Hospital - Mahomet
  • Carle Foundation Hospital - Rantoul

Idaho

  • Idaho State University - Pocatello

Michigan

  • Henry Ford Health System: Harbortown - Detroit

North Carolina

  • University of North Carolina - Chapel Hill

Pennsylvania

  • Temple University - Philadelphia

Texas

  • Texas Tech University Health Science Center - Amarillo

Washington

  • Community Health Center of Snohomish County - Everett

Trial Details

FieldValue
Enrollment Target 542 participants
Start Date 2018-09-27
Est. Completion 2024-12-30
Phase NA

Sponsor

Korey Kennelty

5 total trials

What the Registry Record Tells You About NCT03660631

The ClinicalTrials.gov registry entry for NCT03660631 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 542 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (85% lower). The listed sponsor is Korey Kennelty, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which CVRS Intervention is the first listed.

NCT03660631 reports 14 study locations spanning 8 distinct geographic areas - top geographies include Iowa, Illinois, Idaho.

Frequently Asked Questions

What is clinical trial NCT03660631 about?

NCT03660631 is a clinical study titled "Dissemination of the Cardiovascular Risk Service". The objective of this study is to evaluate the implementation of of a remote, pharmacist-led cardiovascular risk service (CVRS) in 12 large, organizationally and culturally diverse hospitals and health-systems, many with high proportions of minority and underserved patients.

What is the current status of trial NCT03660631?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 542 participants. The study started on 2018-09-27. Estimated completion is 2024-12-30.

What conditions does trial NCT03660631 study?

This clinical trial studies the following conditions: Hypertension, Diabetes Mellitus.

What interventions are being tested in trial NCT03660631?

The interventions under investigation include: CVRS Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03660631?

This trial is sponsored by Korey Kennelty, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03660631 being conducted?

This trial has 14 study locations across Idaho, Illinois, Iowa, Michigan, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.